Cancer immunotherapy. a new explanation for some old observations
Kennedy, J.W.
Arizona Medicine 30(5): 347-348
1973
ISSN/ISBN: 0004-1556 PMID: 4573823 Document Number: 65788
Document emailed within 1 workday
Related Documents
Mathé, G.; Halle-Pannenko, O.; Bourut, C. 1973: BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy National Cancer Institute Monograph 39(8): 107-113Bar-Sela, S.; Levo, Y. 1981: Bee venom immunotherapy: clinical and immunologic observations Annals of Allergy 47(6): 460-463
Lindholm, L.H. 1996: Cancer risks and lacidipine--an explanation Lakartidningen 93(43): 3770
Gilbert, E.S. 1994: Smoking as an explanation for the negative relationship between exposure to radon and certain types of cancer Health Physics 67(2): 197-198
Suissa, S.; Pollak, M.; Spitzer, W.O.; Margolese, R. 1989: Body size and breast cancer prognosis: a statistical explanation of the discrepancies Cancer Research 49(11): 3113-3116
Minev, B.R.; Guo, F.; Gueorguieva, I.; Kaiser, H.E. 2002: Vaccines for immunotherapy of breast cancer and prostate cancer: new developments and comparative aspects In Vivo 16(6): 405-415
Chiriva-Internati, M. 2011: Sperm protein 17: clinical relevance of a cancer/testis antigen, from contraception to cancer immunotherapy, and beyond International Reviews of Immunology 30(2-3): 138-149
Takeda, T.; Nakamura, K.; Sato, M.; Takeda, T.; Tomimaru, Y.; Takeda, H. 2014: The effect of immunotherapy and hyperthermia on patients with advanced or recurrent cancer - analyses by cancer type and recurrence form Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(10): 1261-1263
Hattori, T. 1984: Immunotherapy of cancer Nursing Technique 30(4): 518
Lewis, J.J.; Janetzki, S. 1998: A new hotspot for cancer immunotherapy? Cancer Journal from Scientific American 4(5): 298-299
Klein, E. 1974: Studies on cancer immunotherapy New York State Journal of Medicine 74(8): 1384-1387
Sataloff, R.T. 2004: Advances in cancer immunotherapy Ear Nose and Throat Journal 83(10): 665
Costăchel, O.; Iosub, A.; Gutulescu, N.; Mogos, I.; Liciu, F. 1971: Our experience in associated immunotherapy of cancer Archiv für Geschwulstforschung 37(1): 19-32
Gold, P. 1978: Immunology and immunotherapy of colorectal cancer Canadian Journal of Surgery. Journal Canadien de Chirurgie 21(3): 212-213
Cardinali, G. 1979: Chemotherapy and immunotherapy of pulmonary cancer Minerva Medica 70(3): 273-282
Uotila, P. 1993: Prostaglandins, histamine and cancer immunotherapy Duodecim; Laaketieteellinen Aikakauskirja 109(2): 108-118
Geertsen, P.F.; Hermann, G.G.; Claësson, M.H.; Steven, K.; Zeuthen, J.; von der Maase, H. 1990: Interleukin-2 based immunotherapy of cancer Ugeskrift for Laeger 152(47): 3513-3517
Schackert, H.K.; Betzler, M.; Herfarth, C. 1988: Immunotherapy in surgical cancer patients Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 59(5): 317-322
Costanzi, J.J.; Goldstein, A.L. 1973: Immunotherapy: new hope for the cancer patient American Family Physician 8(5): 150-154
Schmitz-Dräger, B.J.; Schattka, S.O.; Ebert, T. 1993: Immunotherapy of superficial bladder cancer Der Urologe. Ausg. a 32(5): 374-381